Natural History of Stroke: Cause and Development
Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Jan 24, 2001
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding stroke better, including its causes and how it develops. Researchers aim to gather important information that will help inform future studies. They will create a registry of patients who have experienced stroke or a transient ischemic attack (TIA), which is a temporary interruption of blood flow to the brain that can cause stroke-like symptoms. The study will involve people aged 18 or older who come to the emergency department at Suburban Hospital in Bethesda, Maryland, with suspected stroke or TIA.
If you or a loved one participates, you can expect to undergo some standard medical tests that are typically done during a stroke evaluation, such as blood tests, heart monitoring (EKG), and imaging scans of the brain (CT and MRI) and heart (echocardiogram). These tests will help researchers gather valuable data about strokes and TIAs. Participants may also be asked to return for follow-up visits at 1, 3, and/or 12 months to see how things have changed over time. It’s important to note that some individuals may not be eligible to join the study, such as those with certain medical devices or conditions that would prevent them from undergoing an MRI.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- • 1. Aged \>=18
- • 2. Presented to participating study site (ED, ICU, or inpatient unit) with or at risk of acute stroke, TIA, or other disturbances of cerebrovascular circulation
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- 1. Subjects with contraindication to MRI scanning will be excluded from any testing which involves the use of MRI. The contraindications include subjects with the following devices or conditions:
- • Central nervous system aneurysm clips
- • Implanted neural stimulator
- • Implanted cardiac pacemaker or defibrillator
- • Cochlear implant
- • Ocular foreign body (e.g. metal shavings)
- • Insulin pump
- • Metal shrapnel or bullet
- • Any implanted device that is incompatible with MRI
- • Subjects with a condition precluding entry in the scanner (e.g. morbid obesity, Claustrophobia, etc.) will not be included in the MRI portion of this study.
- • 2. Pregnancy
About National Institute Of Neurological Disorders And Stroke (Ninds)
The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Bethesda, Maryland, United States
Washington, District Of Columbia, United States
Bethesda, Maryland, United States
Bethesda, Maryland, United States
Washington, District Of Columbia, United States
Patients applied
CG
TN
Trial Officials
Lawrence L Latour, Ph.D.
Principal Investigator
National Institute of Neurological Disorders and Stroke (NINDS)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials